Understanding the Shift: Point-of-Care vs Laboratory-Bound FIA Testing
For decades, fluorescence immunoassay (FIA) testing has been constrained by laboratory-bound instruments, large sample volume requirements, long turnaround times, and high operational costs. This has limited access to timely diagnostics at the point of care. As aging populations increase disease burden and drive demand for early detection, clinics and care facilities are increasingly asking a practical question: does a portable PSA analyzer or a benchtop FIA system better serve their workflow? VivaChek Biotech (Hangzhou) Co., Ltd., operating under its diagnostic product brand VivaDiag, offers both formats within its FIA analyzer lineup, making it a useful case study for comparing the two approaches.
VivaDiag Portable FIA Analyzer VIM300H: Engineered for Mobility
The VivaDiag Portable FIA Analyzer VIM300H represents the portable end of the spectrum. It is a compact, handheld immunofluorescence analyzer built on photoelectric detection principles, paired with a 3.97-inch color touch screen (LCD touch screen) for streamlined operation.
Core Specifications
The VIM300H measures 146 x 77.6 x 55.5 mm and weighs just 370 g, making it genuinely portable for ambulance, field, and bedside use. It supports a test menu of 39 venous-blood parameters and more than 20 capillary-blood-ready parameters, accommodating whole blood, serum, plasma, urine, hair, and other sample types. Operation temperature ranges from 5–40°C, with storage temperature spanning -10–55°C, and the device includes unit conversion functionality.
Battery, Connectivity, and Data Management
A removable and rechargeable lithium battery provides up to 10 hours of continuous operation, enabling use across clinical shifts and mobile workflows without frequent recharging. Connectivity includes USB, Wi-Fi, and Bluetooth (optional), with an optional external Bluetooth printer. The analyzer stores 10,000 results in memory, supporting record keeping and data review across multiple testing sessions. Calibration relies on an ID Card coding system for parameter-specific accuracy. The VIM300H package includes the analyzer, a quality control ID card and test device, a power adapter, a Type C and USB 2-in-1 cable, a protective cover, a user’s manual, and a quick reference guide, with an optional Bluetooth printer, charging station, and backup battery available.
Benchtop-Style FIA Systems: VIM3000 and the Laboratory Model
In contrast, the VIM3000 reflects a prior-generation, benchtop-oriented design suited to fixed-location settings. It measures 192 x 209 x 169 mm and weighs 1.8 kg, substantially larger than the VIM300H. Its 7-inch color touch screen offers a larger display for data review, and it includes a built-in thermal printer, eliminating the need for an external printing accessory. Connectivity extends to an Ethernet port RJ-45, in addition to USB and Wi-Fi, supporting wired laboratory information system integration. Like the VIM300H, it retains a 10,000-result memory and unit conversion capability, with an operation temperature range of 5–40°C.
A further prior model, the VIM220H, illustrates an even lighter-weight alternative: 165 g, with a 1.54-inch LCD display, a rechargeable lithium battery, and an optional Bluetooth printer. However, it has a smaller 999-result memory, no Wi-Fi, and no unit conversion, reflecting trade-offs made for minimal size and weight over display size and connectivity options.
VivaDiag Prostate Specific Antigen (PSA) Test Kit: The Companion Assay
The analyzer choice is only half the equation; the VivaDiag Prostate Specific Antigen (PSA) Test Kit (FIA) is the quantitative assay designed to work across this analyzer family. Prostate cancer is the second most common cancer in men globally, with about 1.47 million new cases and about 400,000 deaths worldwide in 2022, and early prostate cancer often presents with few or no symptoms—underscoring the need for accessible screening tools.
The PSA Test Kit requires only 20 μL of sample and supports whole blood (fingerstick or venipuncture), serum, or plasma, delivering results in 15 minutes. Its measuring range spans 0.1–100 ng/mL for serum/plasma and 0.37–100 ng/mL for whole blood, with a cut-off reference range of 4 ng/mL. Intermediate precision is reported at CV = 4.97% at low concentration, 4.05% at medium concentration, and 4.69% at high concentration, within an operation temperature of 18–25°C. Each kit (catalog number VID24-06-011) includes 25 test devices, 25 buffer tubes, 25 safety lancets, 25 alcohol prep pads, 25 x 20 μL pipettes, 25 x 75 μL pipettes, and 1 ID Card.
Which System Fits Your Clinical Setting?
The practical distinction between the portable VIM300H and the benchtop-style VIM3000 comes down to deployment context. The VIM300H’s lightweight, battery-powered design is suited to primary healthcare settings such as GP clinics and surgeries, community health centers, and township and rural clinics, as well as emergency and pre-hospital environments including ambulances, mobile medical units, and emergency department triage. Its niche applications extend to corporate and school health clinics, retail pharmacy testing services, home healthcare and domiciliary visits, research and field operations, and remote offshore and maritime stations.
The VIM3000, by comparison, is positioned for point-of-care quantitative immunoassay testing in clinical settings that value built-in printing and wired network integration—scenarios where a fixed location and laboratory information system connectivity matter more than portability.
Regulatory Readiness and Market Confidence
Across its FIA analyzer and test kit portfolio, VivaChek Biotech (Hangzhou) Co., Ltd. maintains an EU Quality Management System Certificate under Regulation (EU) 2017/746 on In Vitro Diagnostic Devices, Annex IX Chapter I and III, along with CE Marking under Notified Body Identification Number 0344 (DEKRA). The PSA Test Kit is IVDR-certified for professional use, supporting market access across European priority markets including Germany, France, Italy, Spain, and the UK. All products are intended strictly for use by clinical laboratory professionals and are not intended for self-testing or near-patient testing, reinforcing their role as professional-grade diagnostic tools regardless of whether a facility selects the portable VIM300H or a benchtop-oriented model such as the VIM3000.
https://www.vivachek.com/
Hangzhou Weice Biotech Co., Ltd.
